Business · 26/09/2006Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Clinical Laboratory Improvement Amendments of 1988 Waiver Applications
Summary
The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, related to recommendations for Clinical Laboratory Improvement Amendments of 1988 waiver applications, and is seeking public comment
Original source language: Federal Register — Food and Drug AdministrationOpen original release →